Welcome to DNKO

DNKO, led by advocates, scientists and clinicians for patients with brain cancer and their families. 

We kindly invite you to read through this whole site

Our next milestone is to raise $250,000 for a preclinical pig study that will inform a clinical canine glioma study; the next stop is a Phase I in patients.

Katherine Onk

Co-Founder & CEO

David Needham PhD, DSc

Co-Founder & CSO

Who We Are

Our Vision and Mission

The Tech, LITT + LTSL-Dox

Our Roadmap

DNKO thrives on resonant collaboration and transparency. Please don't hesitate to contact us regarding any form of inquiry: 

Kate@DNKO.net Co-Founder & CEO

David@DNKO.net Co-Founder & CSO

We're particularly interested in collaborating with people who have interest and/or expertise in: